p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index, and 1 are not checked yet; 7 of the 38 sources its claims cite were checked for support.
Abstract
Cellular senescence is a permanent state of cell cycle arrest that protects the organism from tumorigenesis and regulates tissue integrity upon damage and during tissue remodeling. However, accumulation of senescent cells in tissues during aging contributes to age‐related pathologies. A deeper understanding of the mechanisms regulating the viability of senescent cells is therefore required. Here, we show that the CDK inhibitor p21 (CDKN1A) maintains the viability of DNA damage‐induced senescent cells. Upon p21 knockdown, senescent cells acquired multiple DNA lesions that activated ataxia telangiectasia mutated (ATM) and nuclear factor (NF)‐κB kinase, leading to decreased cell survival. NF‐κB activation induced TNF‐α secretion and JNK activation to mediate death of senescent cells in a caspase‐ and JNK‐dependent manner. Notably, p21 knockout in mice eliminated liver senescent stellate cells and alleviated liver fibrosis and collagen production. These findings define a novel pathway that regulates senescent cell viability and fibrosis.
Verified 2026-10-05 · 1 reference not checked yet
Overview
CoChat Summary
TL;DR
p21 (CDKN1A) is required to maintain the viability of DNA damage-induced senescent cells, and its loss triggers ATM/NF-κB/TNF-α/JNK signaling and caspase-dependent death. In mice, p21 knockout reduces senescent cells in fibrotic liver and alleviates liver fibrosis.
Key findings
- p21 knockdown selectively killed DNA damage-induced senescent (DIS) cells: 30% death in IMR-90 DIS cells, 26% reduction in DIS MEFs, 54% reduction in DIS BJ cells, and 60% lower viability in p21−/− MEFs versus WT; H1299 cells showed 75% reduction after p21 shRNA and etoposide.
- p21 knockdown in DIS cells intensified the DNA damage response (increased p-ATM, p-CHK2, γH2AX, p53), resumed DNA synthesis (BrdU incorporation), caused fragmented chromosomes/micronucleation, and increased sub-G1; microarrays showed 1,595 unique genes changed versus 82 in growing cells, with TNF-α mRNA increased 30-fold.
- Death after p21 knockdown was caspase- and JNK-dependent: pan-caspase inhibitor QVD only partially rescued viability (17% increase), while combined QVD plus JNK inhibitor or JNK knockdown completely rescued; p65 knockdown blocked TNF-α production but did not rescue death.
- In CCl4-treated mice, p21−/− livers had significantly fewer senescent cells, detectable apoptotic cells, reduced Sirius Red fibrosis, and lower TGF-β, COL1A1, and α-SMA expression; p21 knockdown also reduced COL1A1 mRNA by 48% at 24 h before cell death.
Methods
- In vitro senescence models used human IMR-90 and BJ fibroblasts, mouse embryonic fibroblasts, and H1299 cells; DIS was induced with etoposide (20 μM for MEFs/H1299, 50 μM for BJ/IMR-90) for 48 h, and OIS with H-RasV12. p21, p53, pRb, p65, or JNK1 were knocked down by siRNA/shRNA; viability was measured with PrestoBlue, with QVD, z-VAD, or SP600125 treatments where indicated.
- Molecular analyses included Affymetrix PrimeView microarrays (3 replicates) with WikiPathways/IPA enrichment, RT–PCR, immunoblotting, immunofluorescence, comet assay, BrdU incorporation, cell cycle flow cytometry, and ImageStreamX γH2AX foci quantification.
- In vivo, WT and p21−/− 8-week-old female mice received CCl4 for 6 weeks (n = 10 per group); livers were analyzed by SA-β-gal, cleaved caspase-3, Sirius Red, and RT–PCR. Statistical significance used Student’s t-test with P < 0.05.
Limitations
- The paper states that direct regulation of JNK phosphorylation and caspases by p21 cannot be excluded, and that further research is required to define the mode of cell death after p21 knockdown (e.g., necrotic or autophagic versus apoptotic).
- The paper states that mice were assigned to experimental groups by genotype without randomization or blinding.
- Evident from the text: the in vitro work relies mainly on fibroblast lines and one cancer line, and the in vivo work is limited to CCl4-induced liver fibrosis in female mice, so generalizability to other senescent cell types, tissues, and aging models is not established; the paper also notes multiple possible mechanisms for fibrosis alleviation that were not fully distinguished.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
4 Valid · 0 Not valid · 21 Not checked · 85 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Senescent cell elimination can indeed increase the proliferative capacity of stem cells and hence support tissue regeneration”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Supportedcites Chang et al, 2016 matched to “Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice” (2016) source
The Abstract (Results/Discussion passages) states that ABT263-mediated clearance of senescent cells 'significantly improved the clonogenicity (Fig. 3c) and long-term engraftment ability of irradiated HSCs' and that in normally aged mice it 'improved the clonogenicity of isolated MuSCs', with the authors concluding that 'selective clearance of SCs by a pharmacological agent is beneficial in part through its rejuvenation of aged tissue stem cells'. The passage on mechanism ('clearance of senescent HSCs by ABT263 treatment can promote the expansion of normal HSC clones') directly supports increased stem-cell proliferative capacity, and restored long-term repopulation/multilineage engraftment supports the regenerative consequence, in mice (HSCs and MuSCs). (LLM, conf=0.85)
- Supportedcites Yosef et al, 2016 matched to “Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL” (2016) source
The Abstract states that 'Elimination of senescent cells from the epidermis leads to an increase in hair-follicle stem cell proliferation', and the Results (ABT-737 eliminates p53-induced senescent cells from skin) report increased Ki67+ and CD34+/CD49fhigh bulge stem cells that 'repopulate the stem cell compartment'. The Discussion extends this to regeneration: 'these findings suggest that the clearance of senescent cells can lead to tissue renewal and improved fitness', with relevance to other tissues (haematopoietic system, ref 42) noted. The claim's hedged modality ('can') matches the source; the only caveat is that the evidence is in mouse epidermis and the authors explicitly did not observe prominent hair regrowth within their time frame. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These cells use autophagy for their maintenance”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Partly supportedcites Young et al, 2009 matched to “Autophagy mediates the mitotic senescence transition” (2009) sourceExperimental — accuracy not yet measured
Our copy confirms that senescent cells run elevated autophagy (Results, LC3-II accumulation and increased long-lived-protein degradation in Ras/MEK senescent IMR90, BJ and embryonic fibroblasts, with intact autophagic flux) and that autophagy is functionally required for the senescence phenotype, including IL6/IL8 production (Results and Discussion, Fig. 4D-E). But the source frames this as mediating the ACQUISITION/ESTABLISHMENT of senescence — 'important for the rapid protein remodelling required to make the efficient transition from a proliferative to a senescent state' (Introduction) — and it explicitly tested the maintenance idea and found against it: 'knockdown of ATG5/7 in established ras senescent BJ cells failed to reverse the senescence arrest... autophagy contributes to, at least, the establishment of senescence arrest' (Results and Discussion, Fig. 4). So the part attributed to this source that it does not support is 'for their maintenance' (ongoing maintenance of the established senescent state); the supported part is autophagy's role in establishing/quality of the senescence phenotype. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“DDR also participates in controlling regulation of the expression of immune ligands on senescent cells that mediate their recognition and consequent elimination by NK cells”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Supportedcites Sagiv et al, 2016 matched to “NKG2D ligands mediate immunosurveillance of senescent cells” (2016) source
The Introduction states that senescent cells present the NKG2D ligands MICA and ULBP2, enabling NK-cell recognition and elimination, and that a DNA damage response regulates ligand expression. The Discussion likewise attributes ligand regulation partly to the DNA damage response and says NKG2D receptor–ligand interaction is necessary for efficient elimination. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Cellular stress induced by persistent DDR is a central mechanism that drives senescence in aging and age‐related diseases”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Supportedcites Campisi, 2013 matched to “Aging, Cellular Senescence, and Cancer” (2013) source
The 'Genomic Damage' subsection (CELLULAR SENESCENCE: CAUSES) states that senescence-efficacious lesions generate persistent DDR signaling, distinct from the transient DDR of mild damage, and 'Activation of Tumor Suppressors' states that persistent DDR signaling appears to initiate the senescence growth arrest, accompanied by stress-responsive p38MAPK/PKC signaling and increased ROS. The aging/age-disease linkage is carried by the Introduction (senescence links multiple aging pathologies, degenerative and hyperplastic) and by SENESCENT CELLS: CHARACTERISTICS, which reports persistent DNA damage foci in aging mouse and primate tissues, plus 'genomic damage—a common cause of cellular senescence' (Immune Clearance). The source hedges some of this ('may senesce primarily', 'appears to initiate') and notes DDR-independent routes (p38MAPK hyperactivation), but it does treat persistent DDR as the central initiating mechanism, matching the claim's scope. (LLM, conf=0.82)
- Not checked yetcites Munoz‐Espin & Serrano, 2014
- Not checked yetcites Ovadya & Krizhanovsky, 2014 matched to “Senescent cells: SASPected drivers of age-related pathologies” (2014) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, the signal intensity of 1,595 unique genes changed significantly in response to p21 knockdown in DIS cells compared to only 82 in growing cells (Fig 2C).”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > Molecular pathways activated after p21 knockdown in DIS cells
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
63 more claims
Create a free account to see all 110 claims and to verify the 31 references still open.
- Probably not a substantial claim. 23
- It may state two separate claims as one. 24
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence also is associated with upregulation of anti-apoptotic proteins of the BCL-2 family, particularly BCL-2, BCL-Xl, and BCL-W [14,15,143,144]”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [144]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“p21 upregulation has also been suggested as a mechanism that enables senescent cells to resist apoptosis, thereby facilitating their retention in tissues (Yosef et al, 2017).”
From Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues (2025) · cites this paper as Yosef et al, 2017
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, p16 might not be a specific or sensitive marker for cellular senescence since not all p16 highly expressing (p16high) cells are necessarily senescent [4] and some senescent cells do not express p16 [5,6].”
From The heterogeneity of cellular senescence: insights at the single-cell level (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“Upregulation of the cell cycle inhibitor p21 contributes to apoptosis resistance, for example, by inhibiting p53-mediated apoptosis after DNA damage [256,257] and by preventing the cleavage of the apoptosis effector caspase-3 and the activation of the JNK pathway (both required for apoptosis) [144].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > p21 knockout alleviates liver fibrosis
“JQuantification of Sirius Red staining presented in (H).”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > p21 knockout alleviates liver fibrosis
“ISirius Red staining of DIS cells after transduction with sip21 and siCtrl.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > p21 regulates the DNA damage response in senescent cells
“Each specimen was evaluated in triplicate. At least 50 cells were analyzed per replica”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Materials and Methods > Comet assay
“A minimum of 50 individual cells per sample were scored in duplicates.”
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603 · cited 1×
“Preprocessing was performed with the Robust Microarray Averaging algorithm (Irizarry et al , 2003).”
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“Elimination of senescent cells may therefore allow better recovery of tissues, consistent with the finding that senescent cell elimination via transgenic techniques improves aging-associated phenotypes (Baker et al , 2011, 2016).”
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 4×
“…secretory phenotype (SASP) (Coppe et al , 2008), which reinforces senescence arrest in an autocrine manner (Acosta et al , 2008, 2013; Kuilman et al , 2008; Wajapeyee et al , 2008) and mediates immune surveillance of the senescent cells (Sagiv & Krizhanovsky, 2013; Sagiv et al…”
InfluentialNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 2×
“Elimination of senescent cells may therefore allow better recovery of tissues, consistent with the finding that senescent cell elimination via transgenic techniques improves aging-associated phenotypes (Baker et al , 2011, 2016).”
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · cited 3×
“…in the organism promoting local inflammation that drives tissue aging, tissue destruction, and potentially also tumorigenesis and metastasis in a cell non-autonomous manner (Krtolica et al , 2001; Campisi, 2013; Munoz-Espin & Serrano, 2014; Ovadya & Krizhanovsky, 2014; Salama et al , 2014).”
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“…accompanied by the p53 (TP53) target p21 (CDKN1A), inhibits cyclin-dependent kinases (CDKs), thereby preventing phosphorylation of the retinoblastoma protein (pRb) and thus in turn suppressing the expression of proliferation-associated genes (Narita et al , 2003, 2006; Collado et al , 2007).”
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 1×
“…termed the senescence-associated secretory phenotype (SASP) (Coppe et al , 2008), which reinforces senescence arrest in an autocrine manner (Acosta et al , 2008, 2013; Kuilman et al , 2008; Wajapeyee et al , 2008) and mediates immune surveillance of the senescent cells (Sagiv &…”
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 201–300 of 339
Cardioprotective response and senescence in aged sEH null female mice exposed to LPS
Yousef, A., Sosnowski, D. K., Fang, L., Legaspi, R. J., Korodimas, J., Lee, A., Magor, K. E., & Seubert, J. M. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00706.2023 · Cited by 8
ML216 Prevents DNA Damage-Induced Senescence by Modulating DBC1–BLM Interaction
Cui, F., Han, X., Zhang, X., Wang, S., Liang, N., Tan, Q., Sha, W., & Li, J. (2022) · Cells · doi:10.3390/cells12010145 · Cited by 8
“Meanwhile, ML216 facilitated apoptosis following DNA damage (Supplementary Figure S3E,F), presumably as a result of suppressed p21 induction, since p21 could no longer suppress JNK and caspase signaling in response to persistent DNA damage [40].”
BackgroundLoss of p16 does not protect against premature ovarian insufficiency caused by alkylating agents
Liu, F., Wan, Q., Liu, P., Miao, D., Dai, X., & Chen, L. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05476-x · Cited by 8
“Similarly, genetic ablation of p21 also prevents liver fibrosis induced by CCL4 [49].”
BackgroundSakurai, Y., Kubota, N., Takamoto, I., Wada, N., Aihara, M., Hayashi, T., Kubota, T., Hiraike, Y., Sasako, T., Nakao, H., et al. (2023) · Diabetes · doi:10.2337/db23-0150 · Cited by 7
An Integrated Pathogenetic Model of Primary Biliary Cholangitis
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2025) · Livers · doi:10.3390/livers5020015 · Cited by 7
“Apoptosis resistance in senescence is also mediated by the inhibition of p53 via overexpression of the cell cycle inhibitor p21 [382,383] or inhibition of the effector caspase 3, which is a critical step of apoptosis [384].”
In vitro senescence and senolytic functional assays
Ryan, P., & Lee, J. (2025) · Biomaterials Science · doi:10.1039/d4bm01684j · Cited by 7
Multi-omics analysis of canine aging markers and evaluation of stem cell intervention
Li, B., Ding, Y., Han, M., Zhang, Z., Ling, Z., Zhu, W., Xian-jun, Z., Zhang, Y., Lv, C., Li, N., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08333-z · Cited by 7
“With increasing studies, the speci fi city of p16 in senescence has been questioned, as some p16-overexpressing cells are not senescent e.g., macrophages 9 , mesenchymal stem cells 10 ), whereas some senescent cells do not express p16 9,11,12 .”
Emerging roles of senolytics/senomorphics in HIV-related co-morbidities
Kaur, G., Rahman, M. S., Shaikh, S. B., Panda, K., Chinnapaiyan, S., Estevez, M. S., Xia, L., Unwalla, H. J., & Rahman, I. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116179 · Cited by 7
Yu, J.-B., Padanilam, B. J., & Kim, J. (2024) · Cells · doi:10.3390/cells13171475 · Cited by 7
“Furthermore, it has been reported that downregulation of CTGF, induced by genetic inhibition of YAP in resident kidney fibroblasts, attenuates myofibroblast transformation and kidney fibrosis [52–61].”
BackgroundBreathe it in – Spotlight on senescence and regeneration in the lung
Majewska, J., & Krizhanovsky, V. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111550 · Cited by 7
Self-citationuPAR Immuno-PET in Pancreatic Cancer, Aging, and Chemotherapy-Induced Senescence
Pratt, E. C., Mezzadra, R., Kulick, A. R., Kaminsky, S., Samuels, Z. V., Loor, A., de Stanchina, E., Lowe, S. W., & Lewis, J. S. (2024) · Journal of Nuclear Medicine · doi:10.2967/jnumed.124.268278 · Cited by 6
“Numerous cytostatic drug combinations induce senescence, a persistent antiapoptotic process characterized primarily by b -galactosidase ( b -gal) activity ( 3 , 4 ) with additional markers such as P16 INK4A and P21 present ( 5 , 6 ), though not exclusively senescence markers.”
BackgroundMarques, A. R. A., Ferreira, I. S., Ribeiro, Q., Ferraz, M. J., Lopes, E., Pinto, D., Hall, M. J., Ramalho, J. S., Artola, M., Almeida, M., et al. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100825 · Cited by 6
“As previously described (46, 77, 79), p21-mediated cell cycle arrest and Rac1-mediated GMC formation may represent parallel and interconnected mechanisms by which M φ react to the cellular stress elicited by exposure to GlcChol.”
Cho, Y., Lee, W. J., Kim, H. S., Seo, H., Jung, C. H., Ahn, J., Son, H.-S., & Hahm, J. (2025) · GeroScience · doi:10.1007/s11357-025-01713-7 · Cited by 6
Yan, J., Yi, Z., Chen, S., Zhao, R., Shi, J., Shuwen, D., Zhu, J., & Wu, J. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70127 · Cited by 6
“While p16 has historically served as a significant marker in aging research, recent studies suggest that p16 may lack both sensitivity and specificity as a reliable indicator of aging [2, 3].”
Senescent fibroblasts modulate the radiation response of neighboring epithelial cells
Buchholzki, M., Stasch, L. M., Budeus, B., Ketheeswaranathan, V., Sevindik, Z. F., Jendrossek, V., & Klein, D. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02796-z · Cited by 6
“However, the known abbrevation ‘ senescent cell-derived inhibitor 1 (SDI1) ’ for p21, a 164 amino acids containing protein with a molecular weight of about 18 kDa already highlights it ’ s deceisive role in cellular senescence and also aging-related diseases [64 – 66].”
BTG2 acts as an inducer of muscle stem cell senescence
Peng, B., Chen, Y., Wang, Y., Fu, Y., Zeng, X., Zhou, H., Abulaiti, Z., Wang, S., & Zhang, H. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.05.098 · Cited by 6
Lee, P., Sitorus, M. A., Kuo, C., Tsai, B. C., Kuo, W., Lin, K., Lu, S., Lin, Y., Ho, T., & Huang, C. (2024) · Environmental Toxicology · doi:10.1002/tox.24240 · Cited by 6
“48 For example, aged genioglossus muscle stem cells can increase p21 expression and cause serious upper airway injury.”
BackgroundChei, S., Oh, H., Lee, K., Jin, H., Lee, J., & Lee, B.-Y. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.583186 · Cited by 6
“Genes such as p21 and p53, which induce cell cycle arrest, are markers in senescent cells (23).”
BackgroundThe Molecular Interplay Between p53-Mediated Ferroptosis and Non-Coding RNAs in Cancer
Punziano, C., Trombetti, S., Grosso, M., Tornesello, M. L., & Faraonio, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146588 · Cited by 6
“Of note, p21 can create regulatory loops maintaining viability and impeding apoptosis [123] (and ferroptosis [124]). p53 can induce replicative senescence through the direct regulation of the plasminogen activator inhibitor-1 (PAI-1/SERPINE1) [125], arising from downregulation of PI(3)K/AKT–PKB…”
Chronic Kidney Disease and Cellular Senescence
Morevati, M., Tavenier, J., Scheibye‐Knudsen, M., Houlind, M. B., Hedayati, A., & Hornum, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073205 · Cited by 6
“The activation of p21 prevents senescent cells from undergoing apoptosis by constraining JNK signaling and caspase activation [102].”
HIV Protein Nef Induces Cardiomyopathy Through Induction of Bcl2 and p21
Kondrachuk, O., Ciccone, P., Ford, N., Hong, K., Kimura, Y., Zi, J., Yusuf, S., Alkousa, A., Tailor, N., Rajakumar, R., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111401 · Cited by 5
Maeda, A., Fujimura, T., Hirakawa, N., Baba, K., & Kawamoto, S. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00310 · Cited by 5
HIV infection in microglia leads to senescence, triggering activation of neurotoxicity pathwaysPreprint
Mason, S. J., Sreeram, S., Niazi, F., Leskov, K., Levine, A. D., Karn, J., & Valadkhan, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.08.651477 · Cited by 5
Overexpression of βTrCP1 elicits cell death in cisplatin-induced senescent cells
Belmonte‐Fernández, A., Herrero‐Ruiz, J., Limón‐Mortés, M. C., Sáez, C., Japón, M. Á., Mora‐Santos, M., & Romero, F. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07556-6 · Cited by 4
“Furthermore, a more recent publication also demonstrated through interference assays that the downregulation of CDKN1A induced senescent cells ’ death [38].”
Godlewski, A., & Dziaman, T. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1872180 · Cited by 4
“Modulation of these pathways influences whether damaged cells undergo apoptosis or persist within tissues (Yosef et al., 2017; Majewska et al., 2024; Belmonte-Fernández et al., 2025).”
Susantiningsih, T., Fadilah, F., Prijanti, A. R., & Hardiany, N. S. (2024) · Pharmacognosy Journal · doi:10.5530/pj.2024.16.134 · Cited by 4
Balancing senescence and apoptosis: therapeutic insights into aging and cancer
Jan, N., Sofi, S., Mir, A. A., Masoodi, G., & Mir, M. A. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05355-3 · Cited by 4
“Importantly, by suppressing the progression of the cell cycle, p21 prevents apoptosis and is essential for the survival of SnCs. Additional research has demonstrated that p21 inhibits caspase signaling, which helps SnCs survive [71, 73].”
Li, J., Liu, T., Tang, N., Lin, S., Zhang, F., Yuan, W., Zhang, T., Deng, S., Wu, D., & Xu, Y. X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26975 · Cited by 4
Silva, A. O., Bitencourt, T. C., Vargas, J. E., Fraga, L. R., & Filippi‐Chiela, E. C. (2024) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2023-0311 · Cited by 4
“In SnCCs resulting from DNA damage, the downregulation of p21 can trigger cell death through ATM and NF-kβ activation, highlighting the significance of high levels of p21 to maintaining the senescent state (Yosef et al., 2017).”
BackgroundMolecular mechanisms of cellular senescence
Nehme, J., Varela-Eirín, M., & Demaria, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00034-2 · Cited by 4
New frontier for epilepsy treatment through targeting cellular senescence
Bello, S. T., Rafe, M. R., & Huang, F. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111506 · Cited by 3
The Role of Mitochondria-Associated Endoplasmic Reticulum Membranes in Fibrotic Diseases
Wang, F., Wang, H., Zhang, Y., Dan, C., Qin, Y. M., Xie, M. J., & Lyu, X. Y. (2025) · Aging and Disease · doi:10.14336/ad.2025.1087 · Cited by 3
“Furthermore, the absence of the p21 gene in mice has been associated with the removal of senescent cells from liver fibrotic scars, thereby ameliorating liver fibrosis [148].”
Saleh, T., Shboul, S. A., Friehat, K., Melhem, N. Y., Al-Mohtaseb, A. H., Al-Omari, S. O., Matalka, M., Shahin, N. A., Daromar, S., Alhesa, A., et al. (2025) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554251391226 · Cited by 3
“Moreover, CDKN1A (encoding for p21 Cip1 ), a cyclin-dependent kinase inhibitor and a classical hallmark of senescence, 37 exhibited a dramatic upregulation post-NAC (median 37.7 vs. 66.62; p < 0.00001) (Fig.”
InfluentialSenotherapeutics: Emerging pharmacological strategies to target cellular senescence
Nagy, D., Brunner, E., Ekambaram, S., Nagaraja, R. Y., Kordestan, K. V., Patai, R., Kristóf, R., Nagykaldi, M., Chandragiri, S. S., Shanmugarama, S., et al. (2026) · Advances in Translational Research · doi:10.1556/1661.2026.00015 · Cited by 3
Circular Single‐Stranded DNA‐Based Artificial Nanoviruses Mitigate Colorectal Cancer Development
Wang, J., Zhang, P., Huang, Y., Hu, G., Zou, K., Zhou, S., Shao, D., Wang, J., & Song, J. (2025) · Small Methods · doi:10.1002/smtd.202402069 · Cited by 3
Wang, J., Wang, N., Wang, M., Liu, N., Wang, C., Li, N., Mu, L., Jiang, Y., Chen, J., Li, J., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117360 · Cited by 3
Jiang, K., Bao, J., Lou, Z., Liu, F., Xu, K., & Kwan, H. Y. (2025) · Pharmaceuticals · doi:10.3390/ph18020227 · Cited by 3
“Studies have shown that inhibiting p21 expression has the potential to control the progression of liver fibrosis and promote tissue regeneration by eliminating senescent cells [13–15].”
Interplay of autophagy, apoptosis, and senescence in primary biliary cholangitis
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2023) · Exploration of Digestive Diseases · doi:10.37349/edd.2023.00028 · Cited by 3
The Functional and Clinical Consequences of TP53 Mutations in Cancer
Fischer, N. W. (2019) · TSpace (University of Toronto) · Cited by 3
Jatal, R. (2021) · theses.fr (ABES) · doi:10.70675/7299ae44z37f8z4e79z8e0dz67e48edb7144 · Cited by 3
Rad, A. N., Sperger, S., Marsh, L. M., Höetzenecker, K., Lämmermann, I., & Grillari, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.16.623933 · Cited by 3
Jeon, H., Lee, S., Kim, Y., Kim, Y., Shin, S., Lee, Y., Kim, M., Ko, E., Lee, E. J., Song, B. M., et al. (2025) · npj Aging · doi:10.1038/s41514-025-00242-z · Cited by 2
“Given the observed decrease in cell cycle arrest markers and increased cell cycle progression, we further analyzed the expression of the well-known senescencemarkersp16(Cdkn2a)andp21(Cdkn1a),bothofwhicharekey regulatorsofcellcyclearrest 40 .”
Correlations between Aging, Telomeres, and Natural Compounds
Rakoczy, K., Wojdyło, L., Suwała, S., Klasen, K., Kuźnicki, J., Ziętek, M., & Kulbacka, J. (2025) · Aging and Disease · doi:10.14336/ad.2025.0853 · Cited by 2
Singh, V., Anamika, A., Chandra, N., Gupta, V., Gautam, P., Rath, S., Sethi, A. K., Chaurasia, R. N., & Mishra, V. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36295-8.00001-8 · Cited by 2
Chatterjee, E., Dey, B., Sharma, A., Dharavath, A., Naik, A., Singh, H., Basak, S., Pratyusha, B., Ashireddygari, V. R., Tammineni, P., et al. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02310-5 · Cited by 2
“Again, we checked the expression of P21, a key factor that promotes cell cycle arrest and a senescence marker, in DTPs by western blotting [39, 40].”
Wang, Y., Luo, T., Li, C., Zhou, L., Lin, H., & Yang, M. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111189 · Cited by 2
Niculescu, V. F. (2025) · Academia molecular biology and genomics. · doi:10.20935/acadmolbiogen7755 · Cited by 2
Gerosa, L., Malvandi, A. M., Gomarasca, M., Verdelli, C., Sansoni, V., Faraldi, M., Ziemann, E., Olivieri, F., Banfi, G., & Lombardi, G. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae022 · Cited by 2
Genome editing by CRISPR/Cas to generate A549 human lung cancer subline knockout for the p21 gene
Александровна, П. Н., Казанский, Д. Б., Tatarskiy, V. V., & Zamkova, M. A. (2023) · Nauchno-prakticheskii zhurnal «Medicinskaia genetika» · doi:10.25557/2073-7998.2023.11.35-39 · Cited by 1
WANG, J., Yi, L., HUANG, K., Wang, Y., WANG, H., & Zhai, Z. (2024) · Biocell · doi:10.32604/biocell.2024.047871 · Cited by 1
“Senescent cells exhibit elevated expressions of cell cycle regulators, including Cdkn2a (p16) and Cdkn1a (p21), which play a role in regulating cell cycle arrest [25,26].”
BackgroundCircadian clock regulation of myofibroblast fate
Tsoneva, Y., Velikova, T. V., & Nikolaev, G. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111774 · Cited by 1
3D models to study therapy-induced senescence: where do we stand now?
Heydari, Z., Malogolovkin, A. S., Smirnova, O., Lyukmanov, D., Filimonova, A., Shpichka, A. I., Vosough, M., & Timashev, P. S. (2025) · Cytotechnology · doi:10.1007/s10616-025-00774-y · Cited by 1
Fujiwara, M., Shinji, S., Shichi, Y., Nonaka, K., Hasegawa, Y., Takahashi, K., Rokutan, H., Arai, T., & Ishiwata, T. (2025) · BMC Cancer · doi:10.1186/s12885-025-15317-z · Cited by 1
SEVER, A., Erdoğan, M. K., Gündoğdu, R., Geçibesler, İ. H., & Behçet, L. (2025) · Journal of Medical Science · doi:10.20883/medical.e1469 · Cited by 1
Macrophage regulation of extracellular matrix remodeling in aging skeletal muscle
Cui, C., Nazario, J. C., Stephen, I. A., Baranzini, M., Zhang, Y., De, S., Sen, P., Ferrucci, L., & Gorospe, M. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103208 · Cited by 1
Ngumbi, S., Gad, M. S., Mahrous, M., Ijaz, A., Orecchioni, M., Bollinger, K. E., & Bartoli, M. (2026) · Cells · doi:10.3390/cells15141244 · Cited by 1
Vitiligo as a potential degenerative disease: from oxidative stress to cellular senescence
Wang, Y., Chi, J., Wang, T., Zhang, Y., Li, Z., Chen, J., Liu, H., & Li, Q. (2022) · Aging Pathobiology and Therapeutics · doi:10.31491/apt.2022.06.083 · Cited by 1
Liver diseases fibrosis and cirrhosis
Bird, T. G., & Kiourtis, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00004-3 · Cited by 1
Hypoxia and Senescence: Role of Oxygen in Modulation of Tumor Suppression
Eren, M. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-0313-9_5 · Cited by 1
Zabbarova, I. V., Ikeda, Y., & Kanai, A. (2024) · Continence · doi:10.1016/j.cont.2024.101491 · Cited by 1
Yin, Y., Liu, Y., Lu, Y., Tang, Z., Zhu, Z., Zhu, M., Chen, H., Hui, H., Xu, J., & Li, H. (2025) · The FASEB Journal · doi:10.1096/fj.202500962rr · Cited by 1
Senolytic treatment targets aberrant p21-expression to restore liver regeneration in adult micePreprint
Ritschka, B., Knauer-Meyer, T., Mas, A., Plassat, J., Gonçalves, D. S., Jacobs, H., Pedone, E., Vicino, U. D., Cosma, M. P., & Keyes, W. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/759530 · Cited by 1
“This is supported by the findings that protection from apoptosis is a main function of p21, including in senescent cells (Storer et al., 2013; Yosef et al., 2017), and many senolytics, including the one used here, work by blocking anti-apoptotic pathways (Yosef et al., 2016).”
BackgroundLérida‐Viso, A. (2023) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/194709 · Cited by 1
ALTAY, M., & Enstitüsü, F. B. (2022) · Ağrı İbrahim Çeçen University Institutional Repository · Cited by 1
Tatin, X. (2021) · theses.fr (ABES) · doi:10.70675/2e1efdc7ze73bz4150za65dzec3d74346874 · Cited by 1
LKB1, gardien de la prolifération hépatocytaire et de l’intégrité génomique
Maillet, V. (2017) · theses.fr (ABES) · doi:10.70675/866ae571z2346z41d6zb476z517646b200a0
Kumari, R. (2019) · UCL Discovery (University College London)
Die Rolle von MIA (Melanoma Inhibitory Activity) in der melanozytären Seneszenz
Feuerer, L. (2019) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.41000
Wicaksono, B. D. (2020) · ERA · doi:10.7488/era/429
Vascular aging and cardiovascular diseases
Zhao, Y., Wu, A., LiYong, L. I. A. O., Liu, M., XueTing, G. O. N. G., & Tian, X. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2020-0344
Generating Isogenic Models of Li-Fraumeni Syndrome and Restoring p53 using CRISPR
Tran, J. (2020) · TSpace (University of Toronto)
Efeito da superóxido dismutase 2 (SOD2) no processo de transformação celular mediado pelo HPV
Sallas, M. L. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2021.tde-31032022-160453
Senescent cell accumulation & Research-based undergraduate education
Valentijn, F. A. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1121
Low Oxygen Tension Inhibits Senescence in Bone Marrow Mesenchymal Stem Cells (BMSCs)
Bumi, C. (2022) · Journal of Agromedicine and Medical Sciences · doi:10.19184/ams.v8i3.33843
“In this study, p21 could be reduced by low oxygen tension culture so as t to inhibit senescence, which was indicated by low levels of β-galactosidase 21 is an important protein for cell survival because p21-deficient mice cause DNA damage and trigger apoptosis (Yosef et al., 2017).”
BackgroundSharpe, G. (2022) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2022-15147
CELLULAR SENESCENCE AS A CONTRIBUTING MECHANISM TO LATE RADIATION CYSTITIS.
Zabbarova, I. V., Ikeda, Y., & Kanai, A. (2023) · Continence · doi:10.1016/j.cont.2023.100807
Insights into protein-bound uremic toxins in proximal tubule cell senescence and kidney fibrosis
Yang, Y. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1996
Molecular Basis of Stem Cell Senescence
Shaw, E. K., Kim, K. H., & Fábián, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00047-0
Study of the role of the cyclin-dependent kinase inhibitor p21Waf1/Cip1 in cellular senescence
Zapata-Bodalo, I. (2022) · theses.fr (ABES) · doi:10.70675/db01e49aza2daz4404za0f1za3db90231ce9
Therapy induced tumor cell senescence: mechanisms and ways to overcome
Zamkova, M. A., Александровна, П. Н., Tatarskiy, V. V., & Shtil, A. A. (2023) · Biochemistry (Moscow) · doi:10.31857/s0320972523010049
Tan, D., Xu, C., Zhu, Q., Fan, G., & Luo, Q. (2024) · Aging and Disease · doi:10.14336/ad.2024.1262r
“It has been noted that p16 may not be a specific orsensitive marker for cellular senescence, as not all cells highly expressing p16 are necessarily senescent [9], and some senescent cells do not express p16 [10, 11].”
ROS Signaling Controls Lipid Accumulation in HepG2 Cells Driven by Doxorubicin-Induced Senescence
Yun, C., Noh, S. J., Zahrani, H. K., Kim, S. H., & Jung, Y. (2025) · Drug Targets and Therapeutics · doi:10.58502/dtt.24.0020
Endothelial Effects in the Elderly: Fibroblast Regulation in Soft Tissue Healing
Oberringer, M., Jennewein, M., Bubel, M., Guthörl, S., & Pohlemann, T. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70099
Therapy-induced stromal senescence promotes prostate cancer progression and aggressiveness
Pardella, E. (2021) · Use Siena air (University of Siena) · doi:10.25434/pardella-elisa_phd2021
Gottwald, D., Putz, F., Hohmann, N., Büttner-Herold, M., Hecht, M., Fietkau, R., & Distel, L. V. (2020) · Figshare · doi:10.6084/m9.figshare.13204636
Gottwald, D., Putz, F., Hohmann, N., Büttner-Herold, M. J., Hecht, M., Fietkau, R., & Distel, L. V. (2020) · Figshare · doi:10.6084/m9.figshare.13204633
Liu, F., Wan, Q., Liu, P., 苗登顺, Dai, X., & Chen, L. (2024) · Figshare · doi:10.6084/m9.figshare.26573578
Gottwald, D., Putz, F., Hohmann, N., Büttner-Herold, M., Hecht, M., Fietkau, R., & Distel, L. V. (2020) · Figshare · doi:10.6084/m9.figshare.13204639
Gottwald, D., Putz, F., Hohmann, N., Büttner-Herold, M., Hecht, M., Fietkau, R., & Distel, L. V. (2020) · Figshare · doi:10.6084/m9.figshare.13204642
Investigating cellular senescence in the aging tongue.
Chugh, S. (2023) · ResearchWorks at the University of Washington (University of Washington)
Effets des cellules sénescentes sur les processus immunitaires impliqués dans le rejet rénal
Marcoux, M. (2023) · Corpus Université Laval (Université Laval)
Santos, V. G. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Investigating the effects of drug combinations and loss of the PRH/Hhex oncoprotein in CCA cells
Martin, G. (2025) · Nottingham ePrints (University of Nottingham)
Estudio de la ubicuitilación del complejo MRN mediada por SCF(bTrCP/FBXW7): implicaciones biológicas
Belmonte‐Fernández, A. (2023) · Deposito de Investigacion Universidad de Sevilla (University of Seville)
Caractérisation de la sénescence développementale chez l’axolotl
Hiep, J. (2024) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/31576
Contribution of histone modifications to double-strand break repair and aging
González-Bermúdez, L., & Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, D. F. I. D. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- Yosef, R., Pilpel, N., Papismadov, N., Gal, H., Ovadya, Y., Vadai, E., Miller, S., Porat, Z., Ben‐Dor, S., & Krizhanovsky, V.
- Affiliations
- Weizmann Institute of Science (IL)
- Corresponding author
- Krizhanovsky, Valery
- Venue
- The EMBO Journal
- Published
- 2017-06-12
- Volume
- 36
- Issue
- 15
- Pages
- 2280-2295
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC5538795
- OpenAlex
- W2624008928
- Cited by
- 293
- References
- 58
- Citations by year
- 2026: 24 · 2025: 38 · 2024: 39 · 2023: 41 · 2022: 36 · 2021: 50 · 2020: 27 · 2019: 26 · 2018: 11 · 2017: 1
- FWCI
- 13.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Research Council (309688)
- Israel Science Foundation (634/15)
- Bruce Kanter Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, p21, DNA damage response, ATM, NF-κB signaling, JNK signaling, caspase signaling, TNF-α, liver stellate cells, liver fibrosis, collagen synthesis, aging
- MeSH terms
- Animals, Cell Line, Cell Survival, DNA Damage, Gene Expression Regulation, Humans, Caspases, MAP Kinase Signaling System, Cyclin-Dependent Kinase Inhibitor p21, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.